DeFi Technologies to acquire minority stake in Neuronomics

Neuronomics is a leader in applying advanced AI and computational neuroscience to finance, delivering high risk-adjusted returns through innovative strategies. Their proprietary AI models integrate multiple algorithms for improved predictive accuracy and risk management, using a thermodynamics-based portfolio weighting approach to optimize asset distribution. Neuronomics also customizes Large Language Models (LLMs) to predict asset price movements by analyzing real-time market news, providing a competitive edge in identifying emerging investment trends. Additionally, their computational neuroscience research identifies how cognitive biases and emotional responses shape financial behavior, particularly in markets like cryptocurrency, where emotional decision-making is prevalent. 

Since launching a neurofinance-based crypto strategy in 2020, Neuronomics has achieved consistently strong performance with minimal correlation to traditional markets. Their AI-driven quantitative strategies, including one for cryptocurrency, have shown exceptional returns and reduced volatility, demonstrating the firm’s capacity to adapt to dynamic market conditions while minimizing human bias. Neuronomics holds an asset management license from the Swiss Financial Market Supervisory Authority (FINMA), enabling it to manage and administer financial assets on behalf of clients. 

The company has signed an agreement with DeFi Technologies, pioneer in the convergence of traditional capital markets with the world of decentralised finance for the acquisition of an additional stake by subscribing for 10% of the issued and outstanding securities of Neuronomics. This strategic investment aligns with DeFi Technologies' goals of expanding its presence in the asset management space, leveraging Neuronomics' technological innovations and market expertise. DeFiTechnologies, which previously invested and acquired further Swiss companies such as Valour, had previously acquired a toe-hold investment in Neuronomics. Neuronomics' expertise in AI-driven strategies will significantly enhance DeFi Technologies' capabilities, especially as a complement to DeFi Alpha, its specialized arbitrage trading desk, which focuses on identifying and capitalizing on low-risk opportunities within the cryptocurrency market.

Olivier Roussy Newton, Chief Executive Officer of DeFi Technologies, commented: “This strategic investment marks an exciting step for DeFi Technologies as we expand our presence in both asset management and trading. We have been a shareholder and partner of Neuronomics since 2023, and can see how Neuronomics' AI-driven quantitative trading strategies perfectly complement our existing capabilities and align with our broader goals. The Investment will deepen the relationship between Neuronomics and DeFiTechnologies and will not only enhance our expertise in the trading sector but also diversify our revenue streams, especially through DeFi Alpha—our specialized arbitrage trading desk that focuses on low-risk opportunities in the cryptocurrency market. By integrating Neuronomics' cutting-edge strategies, we will strengthen our ability to deliver consistent, market-neutral returns while further advancing our position in both traditional and decentralised finance.”